具有乳头样核特征的非浸润性甲状腺滤泡性肿瘤(NIFTP)七年:不同大陆的接受率与诊断方法差异
该研究通过两轮问卷调查国际内分泌病理讨论组的病理学家,了解NIFTP的采纳率、实践模式变化及诊断标准的统一性,第一轮由48名内分泌病理学家(北美24名、欧洲8名、亚洲/大洋洲16名)完成,第二轮由38名完成。结果显示NIFTP采纳率为94%,但北美病理学家作出NIFTP诊断的频率显著高于其他地区(P=.009);在核评分2的肿瘤中存在显著的核评分与诊断差异(病例2,P<.05),北美和欧洲病理学家对乳头状甲状腺癌样核及NIFTP的阈值倾向于低于亚洲/大洋洲。结论认为尽管各地区的NIFTP采纳率均较高,但中间型乳头状甲状腺癌样核及NIFTP的诊断仍存在显著差异,亚洲/大洋洲的核评分更为保守,这可能解释NIFTP发病率的地域差异。
要点
- NIFTP采纳率为94%,但北美病理学家作出NIFTP诊断的频率显著高于其他地区(P=.009)。
- 核评分2的肿瘤在核评分与NIFTP诊断上存在显著差异(病例2,P<.05)。
- 北美和欧洲病理学家对乳头状甲状腺癌样核及NIFTP的阈值倾向于低于亚洲/大洋洲,亚洲/大洋洲核评分更保守。
核心结论
- 尽管各地区的NIFTP采纳率均较高,但北美病理学家作出NIFTP诊断的频率更高。
- 中间型乳头状甲状腺癌样核及NIFTP的诊断仍存在显著差异,亚洲/大洋洲的核评分更为保守,这可能解释NIFTP发病率的地域差异。
研究设计与样本
- 向国际内分泌病理讨论组的病理学家发放两轮调查问卷,包含关于NIFTP纳入病理实践的多选题及5个肿瘤的全切片图像,以收集核评分与诊断信息。
- 第一轮调查由48名内分泌病理学家完成,包括北美24名、欧洲8名、亚洲/大洋洲16名;第二轮调查由38名完成。
主要发现
- 病理学家对NIFTP的采纳率为94%。
- 北美病理学家作出NIFTP诊断的频率显著高于其他地区(P=.009)。
- 在诊断核改变轻微或发育良好的乳头状甲状腺癌样核病变时一致性最高,而在核改变中度的肿瘤(核评分2)中,核评分与NIFTP诊断存在显著差异(病例2,P<.05)。
- 北美和欧洲执业的病理学家对乳头状甲状腺癌样核及NIFTP的阈值倾向于低于亚洲/大洋洲执业的病理学家。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) was introduced as a new entity replacing the diagnosis of noninvasive encapsulated follicular variant of papillary thyroid carcinoma (PTC). Significant variability in the incidence of NIFTP diagnosed in different world regions has been reported. OBJECTIVE: To investigate the rate of adoption of NIFTP, change in practice patterns, and uniformity in applying diagnostic criteria among pathologists practicing in different regions. METHODS: Two surveys distributed to pathologists of the International Endocrine Pathology Discussion Group with multiple-choice questions on NIFTP adoption into pathology practice and whole slide images of 5 tumors to collect information on nuclear score and diagnosis. Forty-eight endocrine pathologists, including 24 from North America, 8 from Europe, and 16 from Asia/Oceania completed the first survey and 38 the second survey. RESULTS: A 94% adoption rate of NIFTP by the pathologists was found. Yet, the frequency of rendering NIFTP diagnosis was significantly higher in North America than in other regions (P = .009). While the highest concordance was found in diagnosing lesions with mildly or well-developed PTC-like nuclei, there was significant variability in nuclear scoring and diagnosing NIFTP for tumors with moderate nuclear changes (nuclear score 2) (case 2, P < .05). Pathologists practicing in North America and Europe showed a tendency for lower thresholds for PTC-like nuclei and NIFTP than those practicing in Asia/Oceania. CONCLUSION: Despite a high adoption rate of NIFTP across geographic regions, NIFTP is diagnosed more often by pathologists in North America. Significant differences remain in diagnosing intermediate PTC-like nuclei and respectively NIFTP, with more conservative nuclear scoring in Asia/Oceania, which may explain the geographic differences in NIFTP incidence.
引用
- Williams MD, Liu Z, Rossi ED, et al. Seven years of Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): Rate of Acceptance and Variation of Diagnostic Approaches Across Different Continents. J Clin Endocrinol Metab. 2024. PMID: 38874075. doi:10.1210/clinem/dgae354
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。